Journal of Controlled Release : Official Journal of the Controlled Release Society 1994: Vol 31 Index

4 Pages·1994·1.1 MB·English

journal of
controlled
release
Journal of Controlled Release 31 (1994) 323-324
Author Index
Duchéne, D., see Irache, J.M. (31) 181
Abraham, W., see Garrison, M.D. (31) 263 Duffy, J., see Seymour, L.W. (31) 201
Achar, L. and Peppas,N.A., Preparation, characterization and Duffy, J.A., see Blair, J.A. (31) 145
mucoadhesive interactions of poly( methacrylic acid) copolymers Duncan, R., see Seymour, L.W. (31) 201
with rat mucosa (31) 271 Durrer, C., see Irache, J.M. (31) 181
Alireza Mortazavi,S. and Smart, J.D., An in-vitro method for
assessing the duration of mucoadhesion (31) 207 Emara, L.H., The development of slow-release molluscicide in a
Amsden, B.G. and Cheng, Y.-L., Enhanced fraction releasable above biodegradable gelatin matrix (31) 255
percolation threshold from monoliths containing osmotic
excipients (31) 21 Furlani, P., see Pozzi, F. (31) 99
Aso, Y., Yoshioka, S., Li Wan Po, A. and Terao, T., Effect of
temperature on mechanisms of drug release and matrix Gangadharam, P.R.J., see Hsu, Y.-Y. (31) 223
degradation of poly(D,L-lactide) microspheres (31) 33 Garrison, M.D., Doh, L.M., Potts, R.O. and Abraham, W., Effect of
oleic acid on human epidermis: Fluorescence spectroscopic
Behl, C.R., see Gupta, S.K. (31) 229 investigation (31) 263
Blair, 1.A., Mordue (Luntz), A.J., Duffy, J.A. and Wardell, J.L., Gazzaniga, A., see Pozzi, F. (31) 99
Use of metal carboxylate glasses in the controlled release of Gianasi, E., see Orienti, I. (31) 61
bioactive molecules: Culex quinquefasciatus oviposition Goosen, M.F.A., see Zhang, X. (31) 129
pheromone (31) 145 Gray, B.N., see Chen, Y. (31) 49
Blevins, W.E., see Bowersock, T.L. (31) 245 Gresser, J.D., see Hsu, Y.-Y. (31) 223
Bolton, S., see Gupta, S.K. (31) 229 Gupta, S.K., Kumar,S., Bolton,S., Behl,C.R. and Waseem
Borie, D.L., see Bowersock, T.L. (31) 245 Malick, A., Effect of chemical enhancers and conducting gels on
Bowersock, T.L., Woodyard, L., Hamilton, A.J. and DeFord, J.A., iontophoretic transdermal delivery of cromolyn sodium (31) 229
Inhibition of Staphylococci by vancomycin absorbed on
triidodecylmethyl ammonium chloride-coated intravenous Hamilton, A.J., see Bowersock, T.L. (31) 237
catheter (31) 237 Hashida, M. and Takakura, Y., Pharmacokinetics in design of
Bowersock, T.L., Shalaby, W.S.W., Levy,M., Blevins, W.E., polymeric drug delivery systems (31) 163
White, M.R., Borie, D.L. and Park, K., The potential use of Heller, J., see Seymour, L.W. (31) 201
poly( methacrylic acid) hydrogels for oral administration of drugs Henderson, A., see Rajabi-Siahboomi, A.R. (31) 121
and vaccines to ruminants (31) 245 Higuchi, W.I., see Hoogstraate, A.J. (31) 41
Bowtell, R.W., see Rajabi-Siahboomi, A.R. (31) 121 Hijikata, S., see Tabata, Y. (31) 189
Hoogstraate, A.J., Srinivasan, V., Sims, S.M. and Higuchi, W.I.,
Chen, Y., McCulloch, R.K. and Gray, B.N., Synthesis of albumin- Iontophoretic enhancement of peptides: behaviour of leuprolide
dextran sulfate microspheres possessing favourable loading and versus model permeants (31) 41
release characteristics for the anticancer drug doxorubicin (31) Hsu, Y.-Y., Gresser, J.D., Trantolo, D.J., Lyons, C.M.,
49 Gangadharam, P.R.J. and Wise, D.L., In vitro controlled release
Chen, Y.-L., see Lin, S.-Y. (31) 277 of isoniazid from poly( lactide-co-glycolide) matrices (31) 223
Cheng, Y.-L., see Amsden, B.G. (31) 21
Coppola, A., see Orienti, I. (31) 61 Ikada, Y., see Yamaoka, T. (31) 1
Ikada, Y., see Tabata, Y. (31) 189
Davies, M.C., see Rajabi-Siahboomi, A.R. (31) 121 Irache, J.M., Durrer, C., Duchéne, D. and Ponchel, G., In vitro study
Davis, S.S., see McGee, J.P. (31) 55 of lectin-latex conjugates for specific bioadhesion (31) 181
Davis, S.S., see Pozzi, F. (31) 99 Irie, T., see Matsubara, K. (31) 173
DeFord, J.A., see Bowersock, T.L. (31) 237 Ito, F., see Takagi, T. (31) 283
Doh, L.M., see Garrison, M.D. (31) 263 Iwata, H., see Takagi, T. (31) 283
0168-3659/94/$07.00 © 1994 Elsevier Science B.V. All rights reserved
SSDI 0168-3659(94)9999-Z
324 Author Index / Journal of Controlled Release 31 (1994) 323-324
Kissel, T., see Volland, C. (31) 293 Rajabi-Siahboomi, A.R.., Bowtell, R.W., Mansfield, P.,
Kokubo, T., see Otsuka, M. (31) 111 Henderson, A., Davies, M.C. and Melia, C.D., Structure and
Kumar, S., see Gupta, S.K. (31) 229 behaviour in hydrophilic matrix sustained release dosage forms:
2. NMR-imaging studies of dimensional changes in the gel layer
and core of HPMC tablets undergoing hydration (31) 121
Lee, C.-J., see Lin, S.-Y. (31) 277
Rosiak, J.M., Radiation formation of hydrogels for drug delivery
Levy, M., see Bowersock, T.L. (31) 245
(31) 9
Lin, S.-Y., Tsay, W.-J., Chen, Y.-L. and Lee, C.-J., Application of a
new micro FT-IR/DSC technique to the study of the curing
Sarisuta, N. and Punpreuk, K., In vitro properties of film-coated
kinetics of silicone elastomer (31) 277
diltiazem hydrochloride pellets compressed into tablets (31) 215
Li Wan Po, A., see Aso, Y. (31) 33
Schacht, E., see Marre, A.D. (31) 89
Lyons, C.M., see Hsu, Y.-Y. (31) 223
Schreier, H., see Mobley, W.C. (31) 73
Seymour, L.W., see Marre, A.D. (31) 89
Mansfield, P., see Rajabi-Siahboomi, A.R. (31) 121 Seymour, L.W., Duncan, R., Duffy, J., Ng,S.Y. and Heller, J.,
Marre, A.D., Seymour, L.W. and Schacht, E., Evaluation of the
Poly(ortho -ester) matrices for controlled release of the
hydrolytic and enzymatic stability of macromolecular Mitomycin
antitumour agent 5-fluorouracil (31) 201
C derivatives (31) 89
Shalaby, W.S.W., see Bowersock, T.L. (31) 245
Matsubara, K., Irie, T. and Uekama, K., Controlled release of the
Sims, S.M., see Hoogstraate, A.J. (31) 41
LHRH agonist buserelin acetate from injectable suspensions
Smart, J.D., see Alireza Mortazavi, S. (31) 207
containing triacetylated cyclodextrins in an oil vehicle (31) 173
Srinivasan, V., see Hoogstraate, A.J. (31) 41
Matsuda, Y., see Otsuka, M. (31) 111
McCulloch, R.K., see Chen, Y. (31) 49 Tabata, Y., see Yamaoka, T. (31) 1
McGee, J.P., Davis, S.S. and O’ Hagan, D.T., The immunogenicity Tabata, Y., Hijikata, S. and Ikada, Y., Enhanced vascularization and
of a model protein entrapped in poly(lactide-co-glycolide) tissue granulation by basic fibroblast growth factor impregnated
microparticles prepared by a novel phase separation technique
in gelatin hydrogels (31) 189
(31) 55 Takagi, T., Iwata, H., Tashiro, H., Tsuji, T. and Ito, F., Development
Melia, C.D., see Rajabi-Siahboomi, A.R. (31) 121 of a novel microbead applicable to xenogeneic islet
Mobley, W.C. and Schreier,H., Phase transition temperature transplantation (31) 283
reduction and glass formation in dehydroprotected lyophilized Takakura, Y., see Hashida, M. (31) 163
liposomes (31) 73 Tashiro, H., see Takagi, T. (31) 283
Moldenhauer, M.G. and Nairn, J.G., Solubility parameter effects on
Terao, T., see Aso, Y. (31) 33
microencapsulation in the presence of polyisobutylene (31) 150
Trantolo, D.J., see Hsu, Y.-Y. (31) 223
Mordue (Luntz), A.J., see Blair, J.A. (31) 145 Tsay, W.-J., see Lin, S.-Y. (31) 277
Tsuji, T., see Takagi, T. (31) 283
Nairn, J.G., see Moldenhauer, M.G. (31) 150
Nakamura, T., see Otsuka, M. (31) 111 Uekama, K., see Matsubara, K. (1) 173
Ng, S.Y., see Seymour, L.W. (31) 201
Volland, C., Wolff, M. and Kissel, T., The influence of terminal
gamma-sterilization on captopril containing poly (D,L-lactide-co-
O’ Hagan, D.T., see McGee, J.P. (31) 55
glycolide) microspheres (31) 293
Orienti, I., Coppola, A., Gianasi, E. and Zecchi, V., Influence of
physico-chemical parameters on the release of hydrocortisone
Wardell, J.L., see Blair, J.A. (31) 145
acetate from albumin microspheres (31) 61
Waseem Malick, A., see Gupta, S.K. (31) 229
Otsuka, M., Matsuda, Y., Kokubo, T., Yoshihara, S., Nakamura, T.
White, M.R., see Bowersock, T.L. (31) 245
and Yamamuro, T., A novel skeletal drug delivery system using
Wilding, I.R., see Pozzi, F. (31) 99
self-setting bioactive glass bone cement. III: the in vitro drug
Wise, D.L., see Hsu, Y.-Y. (31) 223
release from bone cement containing indomethacin and its
Wolff, M., see Volland, C. (31) 293
physicochemical properties (31) 111
Woodyard, L., see Bowersock, T.L. (31) 237
Wyss, U.P., see Zhang, X. (31) 129
Park, K., see Bowersock, T.L. (31) 245
Peppas, N.A., see Achar, L. (31) 271 Yamamuro, T., see Otsuka, M. (31) 111
Pichora, D., see Zhang, X. (31) 129 Yamaoka, T., Tabata, Y. and Ikada, Y., Body distribution of
Ponchel, G., see Irache, J.M. (31) 181 intravenously administered gelatin with different molecular
Potts, R.O., see Garrison, M.D. (31) 263 weights (31) 1
Pozzi, F., Furlani, P., Gazzaniga, A., Davis, S.S. and Wilding, L.R., Yoshihara, S., see Otsuka, M. (31) I11
The TIME CLOCK* system: a new oral dosage form for fast and Yoshioka, S., see Aso, Y. (31) 33
complete release of drug after a predetermined lag time (31) 99
Punpreuk, K., see Sarisuta, N. (31) 215 Zecchi, V., see Orienti, I. (31) 61
Zhang, X., Wyss, U.P., Pichora,D. and Goosen, M.F.A., A
mechanistic study of antibiotic release from biodegradable
poly(d,l-lactide) cylinders (31) 129
journal of
controlled
release
Journal of Controlled Release 31 (1994) 325-326
Subject Index
Drug release, (31) 111, (31) 129
Acetylated cyclodextrin, (31) 173 Duration of mucoadhesion, (31) 207
Agarose, (31) 283
Albumin, (31) 49 Effect of compression force, (31) 215
Antibiotics, (31) 129 Electroosmosis, (31) 41
Antigen, (31) 245 Enhanced fraction release, (31) 21
Asparagus pea lectin, (31) 181 Enzymatic stability, (31) 89
Ethylcellulose, (31) 150
Bacterial infection, (31) 237 Ethylcellulose film-coated pellets, (31) 215
Bactericidal activity, (31) 237 Ethylene-co-vinyl acetate monolith, (31) 21
Basic fibroblast growth factor, (31) 189
Bioactive material, (31) 111 Fluorescence spectroscopy, (31) 263
Bioactive molecule, (31) 145 5-Fluorouracil, (31) 201
Bioadhesion, (31) 207
Bioartificial pancreas, (31) 283 Gelatin, (31) 189, (31) 255
Biodegradability, (31) 255 Glass formation, (31) 73
Biodegradable hydrogel, (31) 189 Glass transition temperature T,, (31) 33
Biodegradable polymers, (31) 223 Gonadotropin suppression, (31) 173
Biodegradation, (31) 129
Body distribution, (31) 1 Homing device, (31) 163
Bone cement, (31) 111 Hydrocarbon alcohol, (31) 277
Bovine serum albumin, (31) 61 Hydrocortisone acetate, (31) 61
Bulk erosion, (31) 61 Hydrogel, (31) 245
Buserelin acetate, (31) 173 Hydrogels, (31) 271
Hydrolytic stability, (31) 89
Cancer chemotherapy, (31) 201 Hydrophilic matrix, (31) 121
Captopril, (31) 293 Hydroxyapatite, (31) 111
Catheter-related infection, (31) 237 Hydroxypropylmethylcellulose, (31) 121
Chemical enhancers-iontophoresis, (31) 229
Chemotherapy, (31) 223 Indomethacin, (31) 111
Clearance concept-based pharmacokinetic analysis, (31) 163 Intravenous, (31) 237
Colorectal carcinoma, (31) 201 Intravenous gelatin, (31) 1
Conducting gels, (31) 229 In vitro, (31) 111
Controlled release, (31) 55, (31) 121, (31) 201, (31) 223 In vitro/in vivo correlation, (31) 99
Cromolyn sodium, (31) 229 In-vitro release behavior, (31) 293
Curing, (31) 277 Ion-exchange resin, (31) 49
lontophoresis, (31) 41, (31) 229
Degradation mechanism, (31) 33 Islets of Langerhans, (31) 283
Dextran sulfate, (31) 49 Isoniazid, (31) 223
Diffusion, (31) 61
Diltiazem, (31) 215 Lectin-latex conjugates, (31) 181
Doxorubicin, (31) 49 Liposome, (31) 73
Drug delivery, (31) 201 Lyophilization, (31) 73
Drug dispersing phase, (31) 61
Drug loading, (31) 61 Macromolecular drug, (31) 89
0168-3659/94/$07.00 © 1994 Elsevier Science B.V. All rights reserved
SSDI 0168-3659(94)9999-Z
326 Subject Index / Journal of Controlled Release 31 (1994) 325-326
Macromolecular drug carrier, (31) 163 Polymer/mucosa interaction, (31) 271
Mechanical properties, (31) 215 Poly( methacrylic acid), (31) 245, (31) 271
Metal carboxylate glass, (31) 145 Poly(ortho ester), (31) 201
Microbead, (31) 283 Poly(styrenesulfonic acid), (31) 283
Microencapsulation, (31) 150 Poly(D,L-lactide), (31) 33
Micro FT-IT/DSC system, (31) 277 Pulsed release, (31) 99
Microparticle, (31) 55, (31) 61
Microsphere, (31) 49 Release kinetics, (31) 61
Microspheres, (31) 33, (31) 293 Release mechanism, (31) 33
Mitomycin C derivative, (31) 89 Release mechanisms, (31) 129
Molecular weight, (31) 1
Molluscicide, (31) 255 y-Scintigraphy, (31) 99
Mucoadhesion, (31) 181, (31) 207, (31) 271 Self-setting cement, (31) 111
Mucoadhesive, (31) 207 Silicone elastomer, (31) 277
Skeletal drug delivery system, (31) 111
Mycoplasma lectin, (31) 181
Slow release, (31) 255
Solubility, (31) 61
Neovascularization, (31) 189
Solubility parameters, (31) 150
Nernst-Planck equation, (31) 41
Spray-drying, (31) 293
Niclosamide, (31) 255
Staphylococcus, (31) 237
NMR-imaging, (31) 121
y-Sterilization, (31) 293
Stratum corneum, (31) 263
Oleic acid, (31) 263
Sugar, (31) 73
Oral delivery, (31) 245
Sustained release, (31) 173, (31) 189
Oral immunisation, (31) 55
Swelling, (31) 121
Osmotic excipient, (31) 21
Ovalbumin, (31) 55
Tablets, (31) 121
Oviposition pheromone, (31) 145
Targeting efficacy, (31) 163
Temperature effect, (31) 277
Pasteurella haemolytica, (31) 245
Thermal crosslinking, (31) 61
Pellets compressed into tablets, (31) 215 Tissue granulation, (31) 189
Penetration enhancement, (31) 263 Tomato lectin, (31) 181
Peptide delivery, (31) 41 Transdermal drug delivery, (31) 263
Percolation threshold, (31) 21
Transdermal iontophoresis, (31) 229
Phase separation, (31) 55 Transdermal patch, (31) 229
Phase transition, (31) 73 Transdermal penetration enhancement, (31) 41
pH-independent release, (31) 99 Tuberculosis, (31) 223
Physicochemical properties, (31) 111
Physicochemical property, (31) 163 Vaccine, (31) 55, (31) 245
Polyacrylic acid, (31) 207 Vaccine delivery, (31) 245
Poly (D,L-lactide-co-glycolide), (31) 293 Vancomycin, (31) 237
Polyisobutylene, (31) 150
Poly (lactide-co-glycolide), (31) 223 Water-soluble polymer, (31) 1
Polymer, (31) 255